Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America-Reference-Cited by-同舟云学术

Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North America

Published:2022-05-27 Issue:1 Volume:75 Page:64-69
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Kerur Basavaraj,Fiedler Karoline,Stahl Marisa,Hyams Jeffrey,Stephens Michael,Lu Ying,Pfefferkorn Marian,Alkhouri Raza,Strople Jennifer,Kelsen Judith,Siebold Leah,Goyal Alka,Rosh Joel R.,LeLeiko Neal,Van Limbergen Johan,Guerrerio Anthony L.,Maltz Ross M.,Karam Lina,Crowley Eileen,Griffiths Anne M.,Heyman Melvin B.,Deneau Mark,Benkov Keith,Noe Joshua,Moulton Dedrick,Pappa Helen,Galanko Joseph,Snapper Scott,Muise Aleixo M.,Kappelman Michael D.,Benchimol Eric I.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology and Child Health

Reference23 articles.

1. A review on the use of anti-TNF in children and adolescents with inflammatory bowel disease.;Aardoom;Int J Mol Sci,2019

2. Systematic review and meta-analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn ’ s disease.;Ungaro;Aliment Pharmacol Ther,2020

3. Early-onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms.;Pazmandi;Immunol Rev,2019

4. The diagnostic approach to monogenic very early onset.;Uhlig;Gastroenterology,2014

5. The age of gene discovery in very early onset inflammatory bowel disease.;Muise;Gastroenterology,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Services Utilization and Specialist Care in Pediatric Inflammatory Bowel Disease: A Multiprovince Population-Based Cohort Study;Inflammatory Bowel Diseases;2024-02-16

2. The Benefit of Early and Frequent Antitumor Necrosis Factor-Alpha Trough Level Determination in Very Early-Onset Inflammatory Bowel Disease;ACG Case Reports Journal;2023-11

3. Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2023-10-17

4. Dose escalation of adalimumab as a strategy to overcome anti-drug antibodies: A case report of infantile-onset inflammatory bowel disease;World Journal of Gastroenterology;2023-10-14

5. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations—Children and Adolescents with IBD;Journal of the Canadian Association of Gastroenterology;2023-09-01